Incyte (INCY) Change in Accured Expenses (2010 - 2026)

Incyte (INCY) reported Change in Accured Expenses of -$84.7 million for Q1 2026, down 213.21% on a YoY basis from $74.8 million in Q1 2025, and down 161.15% quarter-over-quarter from $138.5 million in Q4 2025.

Incyte (INCY) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Incyte has reported Change in Accured Expenses for 17 years, with the latest figure at -$84.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 213.21% year-over-year to -$84.7 million; the trailing twelve-month figure through Mar 2026 stood at -$307.8 million (down 223.94% YoY), and the FY2025 full-year result was -$148.2 million, down 153.13% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$84.7 million, down from $138.5 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $138.5 million in Q4 2025, with the low at -$476.7 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $29.2 million across 5 years, with a median of $71.9 million in 2023.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 2430.46% — and 2025, when it plunged 510.9%.
  • Incyte's Change in Accured Expenses stood at $47.8 million in 2022, then jumped by 143.08% to $116.2 million in 2023, then gained by 11.66% to $129.8 million in 2024, then rose by 6.76% to $138.5 million in 2025, then slumped by 161.15% to -$84.7 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$84.7 million (Q1 2026), $138.5 million (Q4 2025), and $115.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn -84.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -84.73 Mn
Mar 31, 2026 -84.73 Mn
Dec 31, 2025 138.55 Mn
Dec 31, 2025 138.55 Mn
Sep 30, 2025 115.14 Mn
Sep 30, 2025 115.14 Mn
Jun 30, 2025 -476.73 Mn
Jun 30, 2025 -476.73 Mn
Mar 31, 2025 74.84 Mn
Mar 31, 2025 74.84 Mn
Dec 31, 2024 129.77 Mn
Dec 31, 2024 129.77 Mn
Sep 30, 2024 121.74 Mn
Sep 30, 2024 121.74 Mn
Jun 30, 2024 -78.04 Mn
Jun 30, 2024 -78.04 Mn
Mar 31, 2024 105.47 Mn
Mar 31, 2024 105.47 Mn
Dec 31, 2023 116.22 Mn
Dec 31, 2023 116.22 Mn